Evaluation of Kawasaki Disease Risk-Scoring Systems for Intravenous Immunoglobulin Resistance
Top Cited Papers
- 31 May 2011
- journal article
- research article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 158 (5), 831-835.e3
- https://doi.org/10.1016/j.jpeds.2010.10.031
Abstract
No abstract availableKeywords
Funding Information
- National Heart, Lung, and Blood Institute (HL068288, HL068279, HL068285, HL068269, HL068270, HL068281, HL068290, HL068292)
This publication has 12 references indexed in Scilit:
- Corticosteroid therapy for primary treatment of Kawasaki disease – weight of evidence: a meta-analysis and systematic review of the literature2009
- Resistance to Intravenous Immunoglobulin in Children with Kawasaki DiseaseThe Journal of Pediatrics, 2008
- Coronary Artery Involvement in Children With Kawasaki DiseaseCirculation, 2007
- Randomized Trial of Pulsed Corticosteroid Therapy for Primary Treatment of Kawasaki DiseaseThe New England Journal of Medicine, 2007
- Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki diseaseThe Journal of Pediatrics, 2006
- Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatmentEuropean Journal of Pediatrics, 2006
- Prediction of Intravenous Immunoglobulin Unresponsiveness in Patients With Kawasaki DiseaseCirculation, 2006
- Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki diseaseActa Paediatrica, 2006
- Diagnosis, Treatment, and Long-Term Management of Kawasaki DiseaseCirculation, 2004
- Intravenous gamma-globulin treatment and retreatment in Kawasaki diseaseThe Pediatric Infectious Disease Journal, 1998